AN2728 Ointment + AN2728 Vehicle
Phase 1Completed 0 watching 0 views this week💤 Quiet
32
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Plaque-type Psoriasis
Conditions
Plaque-type Psoriasis
Trial Timeline
Nov 30, 2010 → Dec 7, 2010
NCT ID
NCT01258088About AN2728 Ointment + AN2728 Vehicle
AN2728 Ointment + AN2728 Vehicle is a phase 1 stage product being developed by Pfizer for Plaque-type Psoriasis. The current trial status is completed. This product is registered under clinical trial identifier NCT01258088. Target conditions include Plaque-type Psoriasis.
Hype Score Breakdown
Clinical
10
Activity
5
Company
9
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01258088 | Phase 1 | Completed |
Competing Products
18 competing products in Plaque-type Psoriasis